|
Delayed
Australian S.E.
06:28:04 02/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0840 AUD | 0.00% |
|
+7.69% | -44.00% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 43.12 | - | - |
| Change | - | - | 343.99% | -64.24% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 25.22 | 19.72 | 25.72 |
| Change | - | - | 241.42% | -72.8% | -21.81% | 30.43% |
| P/E | -2.64x | -3.27x | -14.3x | -3.65x | -12x | -7.64x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.2x | -0.1x |
| Capitalization / Revenue | - | - | - | - | 4.54x | 4.54x |
| EV / Revenue | - | - | - | - | 2.08x | 2.71x |
| EV / EBITDA | - | - | -11.2x | -2.19x | -4.93x | -4.29x |
| EV / EBIT | - | - | -11.1x | -2.17x | -4.81x | -4.22x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.0840 | 0.0840 | 0.0840 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.65x | - | -2.19x | - | 30.34M | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -71.62x | 13.03x | -68.47x | -.--% | 24.7B | |
| Average | 15.24x | 28.01x | 6.16x | 0.34% | 39.44B | |
| Weighted average by Cap. | 21.64x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
